BioSpace News Archive

BIOREM Technologies Inc. Announces Proposed Private Placement of Up to $1.5 Million of Units

July 2, 2012
·
2 min read
Drug Development

Sosei Group Corporation Announces Successful Completion of Phase I Study for SO-1105 for the Treatment of Oropharyngeal Candidiasis

July 2, 2012
·
2 min read
Drug Development

Argos Therapeutics, Inc. Receives FDA Approval of Special Protocol Assessment for AGS-003 Phase 3 Trial

July 2, 2012
·
1 min read
Policy

NeuroSigma, Inc. Receives Global Quality Control Certification

July 2, 2012
·
5 min read
Biotech Beach

Questcor Pharmaceuticals, Inc. (Headquarters) to Present at JMP Securities Healthcare Conference

July 2, 2012
·
1 min read
Drug Development

ImmunoCellular Therapeutics, Ltd Provides Update on Phase II Clinical Trial of ICT-107 for Treatment of Glioblastoma

July 2, 2012
·
1 min read
Pharm Country

ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) Release: Cold-EEZE® Announces Launch of NEW Cold-EEZE® Cold Remedy Daytime/Nighttime QuickMelts® and Achieves Nationwide Product Distribution

July 2, 2012
·
2 min read
Business

Medgenics, Inc. Appoints Former Celgene CEO Dr. Sol Barer as Chairman of the Board

July 2, 2012
·
1 min read
Bio NC

Conversion Right Triggered for Laboratory Corporation of America Holdings (LabCorp)’s Zero Coupon Convertible Subordinated Notes Due 2021

July 2, 2012
·
1 min read
Biotech Bay

Auxogyn, Inc. Presents New Data Showing the Ability of Eeva(TM) to Non-Invasively Predict Embryo Advancement With Increased Accuracy

July 2, 2012
·
3 min read